Ayala Pharmaceuticals, Inc. 

NJ

  SEC # 1100397

        

Click to view...

Registrant

About

Filings

Files

Relationships

Names

Topics

Web

Registrant
 SEC-Registered:  12/6/99   —   First EDGAR Filing:  12/14/99   –   Last Filing:  5/9/24 

Possible Termination of Registration and/or Duty to File Reports per 5/9/24 Form 15

Business Address      On:  5/9/24       [ Map ]		Mailing Address      On:  5/9/24       [ Map ]
9 Deer Park Drive Suite K-1 Monmouth Junction, New Jersey  08852 U.S.A.

Phone #		Organized In		Fiscal-Year End		IRS #		SEC CIK		SEC File #
+1 732-545-1590		Delaware, U.S.A.		12/31/yy		84-1521955		0001100397		001-36138

Market: Symbol:  OTC: ADXS

Industry Classification

GICS – Global Industry Classification Standard:        Sector      →    Sub-Industry   Health Care Biotechnology   ICB – Industry Classification Benchmark:               Industry    →       Subsector      Health Care Biotechnology   SIC:     Code      U.S. Industry      Through      Source      Filings-Review Office 2834 Pharmaceutical Preparations 2024 SEC Office of Life Sciences 9995 Non-Operating Establishments 2005 SEC Office of Real Estate & Construction

        

Management
Director   In   I.B.F. Management Ltd. 2024   Israel Biotech Fund GP Partners II, L.P. 2024   Israel Biotech Fund GP Partners, L.P. 2024   Israel Biotech Fund II, L.P. 2024   Israel Biotech Fund I, L.P. 2024   MD   Sidransky David 2013-2023   MA   Bisker-Leib Vered 2023   Cabilly Yuval 2023   CA   Goldberg Murray A 2023   IN   Martell Bridget A 2023   Orbach Pini 2023   CA   Spiegel Robert J. 2023   NJ   Appel Roni 2004-2020   PA   Patton James P 2004-2020   NJ   Berman Richard J 2005-2020   MD   Khleif Samir N 2014-2020 ↓List Pre-2020 Directors				Officer  Since  Most-Recent Title   In   Golan Roy Chief Financial Officer 2023   NJ   Gitelman Igor Chief Accounting Officer 2021   NJ   Berlin Kenneth A 2018 President & CEO 2020   NJ   Gutierrez Andres 2018 Executive Vice President & CMO 2020   NJ   Henderson Molly 2018 Executive Vice President & CFO 2020 ↓List Pre-2019 Officers

        

        

        

        

Securities
Market:  Symbol       (Prices)   OTC:  ADXS   _________  Symbol source:  SEC  As of:  5/13/24		CUSIP, CINS or PPN       Description ← Symbol   Issuer Issue (Class or re: Filing — Name)      To 2024:   007624 007624·10·9     Common 007624·01·8     Options 007624·11·7     W Exp 07/15/201 007624·20·8     Common New 007624·30·7     Common New — COM0.001 ← ADXS 007624·40·6     Common Shares      To 2024:   05465V 05465V·10·8     Common — COM ← AYLA _________  Classes source:  Form 13F Filings that list Section 13(f) Securities